robertvince

Author Archives

Aethlon Medical® Reports Rapid and Sustained Virologic Response Rates in Hepatitis C (HCV) Treated Patients SAN DIEGO, Dec. 2, 2014 /PRNewswire/ — Aethlon Medical, Inc. (AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, today reported final clinical outcomes, including rapid virologic response (RVR) and sustained virologic response (SVR) rates, […]

242 Million Copies of Ebola Virus Removed from Patient during Treatment, Physician Reports at American Society of Nephrology Annual Meeting SAN DIEGO and PHILADELPHIA, Nov. 14, 2014 /PRNewswire/ — The Aethlon Hemopurifier® was used in the successful treatment of a critically-ill Ebola-infected patient in Frankfurt, Germany, according to data presented today at the American Society […]

When I purchased Stellar Biotechnologies, it was a speculative investment with a compelling story. These are the microcap stocks I like to get involved with. Holding it for the past year was a roller coaster ride, and gave me reason to question my investment. The more research I did, the more I felt confident in […]

Recent Author Comments

On Friday File: Buys in Small Tech and Baby Berkshires

Interesting article on Parkinson's disease: https://parkinsonsnewstoday.com/2018/08/03/mitochondria-transport-disruption-causes-parkinsons-study/[...]

Go to Comment »
On The 2017 - 2018 Flu Outbreak: How Bad Is It Really, and What to Do?

Some in the know would disagree with the tuna/vax argument: Misleading Mercury-exposure Comparisons: Thimerosal-preserved Flu Shot Versus the Eating of Tuna Fish by: Paul G. King, PhD Initial Comments First of all the common statement: “My doctor[...]

Go to Comment »
On Microblog: Introducing: The Blind Squirrel and his Traveling Show of Nuts

Welcome back old friend. I too have been 'lurking' ;) Don't want to comment publicly about the recent turmoil but good to see you're still around. RV[...]

Go to Comment »
On Biotech Discussion... continued

Just my response to the bad news. There was only one other post when I posted it so I thought it would be pretty clear what I was commenting on.[...]

Go to Comment »
On Biotech Discussion... continued

That just downright sucks![...]

Go to Comment »
On The Rest of the 12 Biotechs of Christmas

$ESPR sp http://www.investors.com/news/technology/esperion-dive-on-amgen-heart-study-counter-intuitive-on-pricing/?src=A00220A[...]

Go to Comment »
On Microblog: Music biz....nothing to do with investing

Great stories Alan. I know what you mean about the moog beasts. They actually just re-released that modular monster, albeit not the same , hopefully with a bit more stability. I've got a collection of old keyboards that would love to poop out the second[...]

Go to Comment »
On Microblog: Music biz....nothing to do with investing

This is what happens when you don't read SG every day. I had no idea you created this spot. Now I'm going to sit back and read the article, i'm sure I'm going to love it.[...]

Go to Comment »
On The Rest of the 12 Biotechs of Christmas

Alan, would love to read about some of your encounters with the music world. Closest I got to Keith besides seeing him in concert many times is owning a Moog synthesizer amplification system that was rumored to have been engineered for him. Still have it[...]

Go to Comment »
On The Rest of the 12 Biotechs of Christmas

$ClassicRock Not sure of your take on John Wetton, but just a fyi for those in the northeast, Amex presale of “An Extraordinary Life” Celebration of his music today. Playing at the Bergen Pac in NJ on 6-17 From their website: An Extraordinary Life”[...]

Go to Comment »
On The Rest of the 12 Biotechs of Christmas

Hi folks, as promised a prostate update on my dad (who I incorrectly said was 98, actually 97). When last I wrote, my dad had seen a urologist in Florida that was learned in the use of the Urolift procedure (http://urolift.com/), brought to my attention [...]

Go to Comment »
On Noblecon13 Live Blog

Good morning Gumfolks, just wanted to post an update bout dad and and his prostate. He went to see a doctor in Florida who uses the new Urolift procedure. In an effort to see if he was a good candidate, they ran a camera up to have a look at the path t[...]

Go to Comment »
On The Twelve Biotechs of Christmas: One

I love this community. My dad is 98 and his prostate has gotten so enlarged that he can no longer urinate, which is also affecting his sleep. I stroll over to the gumshoes every time I'm looking for some hope or guidance, the good Dr. KSS has already pro[...]

Go to Comment »
On The Tao of Recro

The Motley Fools comments on ZFGN, basically everyone is clueless: http://www.fool.com/investing/general/2015/10/13/why-zafgen-is-down-54-over-the-last-two-days.aspx?source=eogyholnk0000001&utm_source=yahoo&utm_medium=feed&utm_campaign=article[...]

Go to Comment »
On The Tao of Recro

The street bio hack Adam F chiming in on Zafgen: http://www.thestreet.com/story/13323265/1/zafgen-finally-speaks-about-stock-plunge-but-says-nothing.html?puc=yahoo&cm_ven=YAHOO[...]

Go to Comment »
On Cisco, Chang & Charlie

Arch Therapeutics Initiates Research and Development Collaboration With CURAM Centre for Research in Medical Devices http://finance.yahoo.com/news/arch-therapeutics-initiates-research-development-115700652.html[...]

Go to Comment »
On A Biotech Long Idea Brought to You on Bended Knee

The awesomeness continues![...]

Go to Comment »
On Cisco, Chang & Charlie

Not sure if this was posted yet: Zafgen Completes Enrollment of U.S. Phase 3 Trial of Beloranib in Prader-Willi Syndrome BOSTON, May 28, 2015 (GLOBE NEWSWIRE) -- Zafgen, Inc. (ZFGN), a biopharmaceutical company dedicated to significantly improving the he[...]

Go to Comment »
On The Last Samurai Biotech

Trying to keep one less doctor in the OR? http://www.washingtonpost.com/business/economy/new-machine-could-one-day-replace-anesthesiologists/2015/05/11/92e8a42c-f424-11e4-b2f3-af5479e6bbdd_story.html[...]

Go to Comment »
On The Last Samurai Biotech

Yikes Anamorph, thanks for bringing that to my attention.[...]

Go to Comment »

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

Connect with Travis

website designed by Gravity Switch